Skip to main content

Table 1 Recent studies on the treatment of PD model by INA of stem cells

From: Advances in intranasal application of stem cells in the treatment of central nervous system diseases

Authors

Year

Animal models

Cell types

No. of cells per animal

Markers

Results

Danielyan et al. [56]

2011

Unilateral

6-OHDA

rat model

MSCs

1 × 106

EGFP

MSCs survived for at least 4.5 months and began to proliferate. TH levels in damaged-side substantia nigra and motor symptoms were improved.

Bossolasco et al. [61]

2012

Bilateral

6-OHDA

rat model

hMSCs

2 × 106

NIR815

Strong near infrared signals observed in the olfactory epithelium 10 min after INA, which moved inside the nose within 30 min and disappeared after 1 h. No signal in coronal section of the brain.

Danielyan et al. [62]

2014

(Thy1)-h [A30P] αS mice

BM-MSCs

1 × 106

EGFP

EGFP-expressing MSCs detected in olfactory bulb, cortex, amygdala, striatum, hippocampus, cerebellum, and brainstem 7 days after INA. Predominant distribution in olfactory bulb and brainstem.

Salama et al. [63]

2017

Rotenone mouse model

MSCs

5 × 105

None

At 70 days after INA, striatum TH staining showed the density of TH fibers was protected by MSCs, proving their protective effect on dopaminergic neurons.

Li et al. [46]

2017

MPTP mouse model

BM-NSCs

3 × 105

None

At 14–15 days after INA, animals’ behavior improved significantly, and combination therapy with fasudil enhanced this effect.

Bagheri-Mohammadi et al. [50]

2019

Bilateral

6-OHDA

mouse model

hEDSCs

1 × 105, 5 × 105, 1 × 106

GFP

At 30, 60, 90, and 120 days after INA, animals’ behavior improved significantly, which was most significant in 5 × 105 cells per animal group. The results of TH staining in striatum were improved significantly

Simon et al. [49]

2019

MPTP mouse model

DPSCs

5 × 105

PKH26

At 7 days after INA, labeled cells were observed in the substantia nigra. By week 4, the TH staining of substantia nigra improved significantly. Obvious effect in several behavioral results were shown.

  1. BM-MSCs bone marrow-derived mesenchymal stem cells, BM-NSCs bone marrow-derived neural stem cells, hEDSCs human endometrial mesenchymal stem cells.N